Results 31 to 40 of about 1,013,786 (315)

Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome [PDF]

open access: yes, 2013
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects one third of patients at diagnosis with a further third developing metastatic disease after extirpative surgery.
Antony C P Riddick   +24 more
core   +2 more sources

Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab

open access: yesOncoImmunology, 2020
Gastrointestinal stromal tumor (GIST) is a devastating disease, especially in the setting of metastasis. The natural progression of GIST has been significantly altered by the development of small molecule tyrosine kinase inhibitors (TKIs), including ...
Brett A. Schroeder   +6 more
doaj   +1 more source

Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study

open access: yesBiomedicines, 2022
The prognosis for patients with penile squamous cell carcinoma metastatic to regional lymph nodes or distant sites remains poor with limited treatment options, especially after the failure of first-line chemotherapy. Clinical trials evaluating the use of
Dalia Kaakour   +3 more
doaj   +1 more source

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]

open access: yes, 2007
Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan   +5 more
core   +1 more source

Metastatic ghost cell odontogenic carcinoma: description of a case and search for actionable targets

open access: yesRare Tumors, 2015
Ghost cell odontogenic carcinoma (GCOC) is an exceedingly rare malignant tumor on the spectrum of already uncommon odontogenic or dentinogenic tumors.
Maximilien J. Rappaport   +2 more
doaj   +1 more source

Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials

open access: yesFrontiers in Pharmacology, 2023
Background: Metastatic castration-resistant prostate cancer (mCRPC) presents significant treatment selection challenges due to limited therapeutic options.
Yang Liu   +8 more
doaj   +1 more source

The phenotypic heterogeneity of tumor-derived cells in the bloodstream of pancreatic cancer patients

open access: yesFrontiers in Cell and Developmental Biology
IntroductionPancreatic cancer (PC) remains an aggressive malignancy with poor clinical outcomes, underscoring the need for novel biomarkers to monitor patients.
Chrysoula Tagari   +12 more
doaj   +1 more source

Malignant melanoma of breast: A unique case with diagnostic dilemmas

open access: yesIndian Journal of Pathology and Microbiology, 2014
Melanomas arising in the skin, mucous membranes, and eye are encountered commonly than melanomas involving the breast. Melanomas in the breast are usually metastatic. Primary melanoma of the breast is extremely rare.
Jayasudha A. Vasudevan   +3 more
doaj   +1 more source

Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer

open access: yesFrontiers in Oncology, 2020
PurposeSingle extracranial metastases from ovarian and uterine malignancies have historically been treated with surgery or conventional radiation. We report mature local control (LC), overall survival (OS), progression free survival (PFS), and toxicity ...
Nima Aghdam   +12 more
doaj   +1 more source

Management and Outcomes of Metastatic and Recurrent Malignant Phyllodes Tumors of the Breast: A Systematic Literature Review

open access: yesEuropean Journal of Breast Health, 2023
To summarize the evidence on the current management and outcomes for metastatic and recurrent malignant phyllodes tumors (MPTs) of the breast. A systematic literature review of all cases of metastatic or recurrent MPTs of the breast published between ...
Elaheh Samii   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy